UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation

Scientific reports, 2021-07, Vol.11 (1), p.13908-13908, Article 13908

2021

Volltextzugriff (PDF)

The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation

Scientific reports, 2021-03, Vol.11 (1), p.5920-5920, Article 5920

2021

Volltextzugriff (PDF)

Risk of major bleeding in elderly patients with atrial fibrillation on direct oral anticoagulants: real world experience

International journal of clinical pharmacy, 2020-04, Vol.42 (2), p.445-452

2020

Volltextzugriff (PDF)

Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry

PloS one, 2016-06, Vol.11 (6), p.e0156943-e0156943

2016

Volltextzugriff (PDF)

High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy

Thrombosis and haemostasis, 2003-12, Vol.90 (6), p.1163-1172

2003

Volltextzugriff (PDF)

Procoagulant State in Heart Failure With Preserved Left Ventricular Ejection Fraction

International Heart Journal, 2009, Vol.50(5), pp.591-600

2009

Volltextzugriff (PDF)

HORMONE REPLACEMENT THERAPY AND VENOUS THROMBOEMBOLISM

Zdravniški vestnik (Ljubljana, Slovenia : 1992), 2008-12, Vol.77 (SUPPIII)

Nina Vene

2008

Volltextzugriff (PDF)

Prognostic impact of haemostatic derangements in chronic heart failure

Thrombosis and haemostasis, 2009-08, Vol.102 (2), p.314-320

2009

Volltextzugriff (PDF)

Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure

Heart and vessels, 2009-07, Vol.24 (4), p.271-276

2009

Volltextzugriff (PDF)

Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation

European journal of clinical pharmacology, 2019-08, Vol.75 (8), p.1069-1075

2019

Volltextzugriff (PDF)

Impact of Asymptomatic Pulmonary Embolism on the Long-Term Prognosis of Patients with Deep Venous Thrombosis

Seminars in thrombosis and hemostasis, 2017-02, Vol.43 (1), p.24-29

2017

Volltextzugriff (PDF)

Clinical guidelines for thrombophilia testing in patients with venous thromboembolism

Zdravniški vestnik (Ljubljana, Slovenia : 1992), 2013-02, Vol.82 (2)

2013

Volltextzugriff (PDF)

Rotational thromboelastometry in ex vivo samples from routine clinical practice patients receiving dabigatran

Clinica chimica acta, 2017-03, Vol.466, p.20-21

2017

Volltextzugriff (PDF)

Management of antithrombotic therapy in patients undergoing regional anesthesia

Zdravniški vestnik (Ljubljana, Slovenia : 1992), 2009-11, Vol.78 (11)

2009

Volltextzugriff (PDF)

Unprovoked proximal venous thrombosis is associated with an increased risk of asymptomatic pulmonary embolism

Thrombosis research, 2014-06, Vol.133 (6), p.1011-1015

2014

Volltextzugriff (PDF)

Late rebound of dabigatran levels after idarucizumab reversal in two patients with severe renal failure

European journal of anaesthesiology, 2017-06, Vol.34 (6), p.400-402

2017

Volltextzugriff (PDF)

Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations

Annals of clinical biochemistry, 2016-07, Vol.53 (4), p.446-451

2016

Volltextzugriff (PDF)

Prevention of Venous Thromboembolism in Hip and Knee Arthroplasty

Zdravniški vestnik (Ljubljana, Slovenia : 1992), 2010-03, Vol.79 (3)

2010

Volltextzugriff (PDF)

Idarucizumab for dabigatran reversal in daily clinical practice: A case series

European journal of anaesthesiology, 2020-10, Vol.37 (10), p.874-878

2020

Volltextzugriff (PDF)

Dabigatran Concentration: Variability and Potential Bleeding Prediction In “Real–Life” Patients With Atrial Fibrillation

Basic & clinical pharmacology & toxicology, 2015-11, Vol.117 (5), p.323-329

2015

Volltextzugriff (PDF)

Preprečevanje venskih trombembolij pri ginekoloških operacijah

Zdravniški vestnik (Ljubljana, Slovenia : 1992), 2015-12, Vol.84 (11)

2015

Volltextzugriff (PDF)

HORMONE REPLACEMENT THERAPY AND VENOUS THROMBOEMBOLISM

Zdravniški vestnik (Ljubljana, Slovenia : 1992), 2008-01, Vol.77

Vene, Nina

2008

Volltextzugriff (PDF)

PREVENTION OF VENOUS THROMBOEMBOLISM IN GYNECOLOGIC SURGERY

Zdravniški vestnik (Ljubljana, Slovenia : 1992), 2015-12, Vol.84 (11)

2015

Volltextzugriff (PDF)

Preprecevanje venskih trombembolij pri ginekoloskih operacijah

Zdravniški vestnik (Ljubljana, Slovenia : 1992), 2015-11, Vol.84 (11)

2015

Volltextzugriff (PDF)

An Overview of the Anticoagulant Drugs Used in Routine Clinical Practice

Vene, Nina

2018

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(33)
Slowenisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation

The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation

Risk of major bleeding in elderly patients with atrial fibrillation on direct oral anticoagulants: real world experience

Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry

High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy

Procoagulant State in Heart Failure With Preserved Left Ventricular Ejection Fraction

HORMONE REPLACEMENT THERAPY AND VENOUS THROMBOEMBOLISM

Prognostic impact of haemostatic derangements in chronic heart failure

Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure

Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation

Impact of Asymptomatic Pulmonary Embolism on the Long-Term Prognosis of Patients with Deep Venous Thrombosis

Clinical guidelines for thrombophilia testing in patients with venous thromboembolism

Rotational thromboelastometry in ex vivo samples from routine clinical practice patients receiving dabigatran

Management of antithrombotic therapy in patients undergoing regional anesthesia

Unprovoked proximal venous thrombosis is associated with an increased risk of asymptomatic pulmonary embolism

Late rebound of dabigatran levels after idarucizumab reversal in two patients with severe renal failure

Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations

Prevention of Venous Thromboembolism in Hip and Knee Arthroplasty

Idarucizumab for dabigatran reversal in daily clinical practice: A case series

Dabigatran Concentration: Variability and Potential Bleeding Prediction In “Real–Life” Patients With Atrial Fibrillation

Preprečevanje venskih trombembolij pri ginekoloških operacijah

HORMONE REPLACEMENT THERAPY AND VENOUS THROMBOEMBOLISM

PREVENTION OF VENOUS THROMBOEMBOLISM IN GYNECOLOGIC SURGERY

Preprecevanje venskih trombembolij pri ginekoloskih operacijah

An Overview of the Anticoagulant Drugs Used in Routine Clinical Practice

Suchergebnisse filtern